Original Research
Accepted on 15 May 2025
Dysregulated monocyte compartment in PACS patients
Frontiers in Immunology
doi 10.3389/fimmu.2025.1613034
43,842 Publications
Volume 16 - 2025
Editorial
Accepted on 15 May 2025
Harnessing the Power of Single Cell Omics Technologies to unravel the Complexity of Immunology/Tumor Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1628120
Original Research
Accepted on 15 May 2025
The contribution of BTK signalling in myeloid cells to neuroinflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1595069
Original Research
Accepted on 15 May 2025
Distinct Metabolomic Signatures in Allergic Rhinitis with Concurrent Chronic Spontaneous Urticaria: An Untargeted Metabolomics Analysis Reveals Novel Biomarkers and Pathway Alterations
Frontiers in Immunology
doi 10.3389/fimmu.2025.1555664
Original Research
Accepted on 15 May 2025
Resistance training alleviates muscle atrophy and muscle dysfunction by reducing inflammation and regulating compromised autophagy in aged skeletal muscle
Frontiers in Immunology
doi 10.3389/fimmu.2025.1597222
Original Research
Accepted on 15 May 2025
Using technology for patient-centered care at home after CAR T-cell therapy or bone marrow transplant: a prospective feasibility study
Frontiers in Immunology
doi 10.3389/fimmu.2025.1403249
Original Research
Accepted on 15 May 2025
Povetacicept (ALPN-303; TACI vTD-Fc), an Enhanced, Potent Dual Inhibitor of BAFF and APRIL, Ameliorates Experimental Autoimmune Myasthenia Gravis in C57BL/6N Mice
Frontiers in Immunology
doi 10.3389/fimmu.2025.1533093
Editorial
Accepted on 15 May 2025
Editorial: Immune Cell Therapy Approaches Targeting Tumor Microenvironment
Frontiers in Immunology
doi 10.3389/fimmu.2025.1628689
Original Research
Accepted on 15 May 2025
Cord Blood-Derived, Engineered Invariant Natural Killer T Cells as a Platform for Allogeneic
Frontiers in Immunology
doi 10.3389/fimmu.2025.1621260
Original Research
Accepted on 15 May 2025
The Heterogeneity of Genomic Alterations, Metastatic Patterns and Immune Microenvironment in Metastatic Ovarian Cancer Originating from Colorectal Cancer
Frontiers in Immunology
doi 10.3389/fimmu.2025.1593439
Original Research
Accepted on 15 May 2025
Therapeutic Implications of Cancer-Associated Fibroblast Heterogeneity: Insights from Single-Cell and Multi-Omics Analysis
Frontiers in Immunology
doi 10.3389/fimmu.2025.1580315
Original Research
Accepted on 15 May 2025
A Novel Mitochondrial Autophagy and Aging-Related Gene Signature for Predicting Ovarian Cancer
Frontiers in Immunology
doi 10.3389/fimmu.2025.1594021
Original Research
Accepted on 15 May 2025
The Potential of ME1 in Guiding Immunotherapeutic Strategies for Ovarian Cancer: Insights from Pan-Cancer Research
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571842
Review
Accepted on 15 May 2025
C-Reactive Protein: The Nexus Between Inflammation and Protein Misfolding Diseases
Frontiers in Immunology
doi 10.3389/fimmu.2025.1612703
Original Research
Accepted on 15 May 2025
Diagnostic utility of IL-18 plasma levels serves as a useful marker forin distinguishing abdominal from non-abdominal sepsis
Frontiers in Immunology
doi 10.3389/fimmu.2025.1591262
Perspective
Accepted on 15 May 2025
Nanomaterials and Immune Checkpoint Inhibitors in Cancer Immunotherapy： The Synergistic Innovation Prospects
Frontiers in Immunology
doi 10.3389/fimmu.2025.1582774